The fusion genes of TMPRSS2 and ETS oncogenes are associated with aggressive lesions, poor prognosis, and early-onset PCa (Tomlins et al., 2006; Tomlins et al., 2005; Verrijdt, et al., 2003). The gene discussed is TMPRSS2; the disease is posterior cortical atrophy.